Usefulness of CD3 or CD6 anti-T monoclonal antibodies in the treatment of acute corneal graft rejection.
Ippoliti
G
G
Clinica Medica II, University of Pavia, Italy.
Fronterrè
A
A
D000208:Acute Disease; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000945:Antigens, Differentiation, T-Lymphocyte / Q000276:immunology*; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D017252:CD3 Complex; D016039:Corneal Transplantation; D006084:Graft Rejection; D006801:Humans; D011183:Postoperative Complications / Q000628:therapy; D011948:Receptors, Antigen, T-Cell / Q000276:immunology*; D013601:T-Lymphocytes / Q000276:immunology*
D000911:Antibodies, Monoclonal; D000945:Antigens, Differentiation, T-Lymphocyte; D000961:Antilymphocyte Serum; D017252:CD3 Complex; D011948:Receptors, Antigen, T-Cell